Larsucosterol (trimethylamine)

• CAT Number: I042841
• Molecular Formula: C30H46O5S.0.45C3H9N
• Molecular Weight: 509.32
• Purity: ≥95%
• IUPAC Name: N,N-dimethylmethanamine;[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
• InChI: InChI=1S/C27H46O5S.C3H9N/c1-18(7-6-14-25(2,3)28)22-10-11-23-21-9-8-19-17-20(32-33(29,30)31)12-15-26(19,4)24(21)13-16-27(22,23)5;1-4(2)3/h8,18,20-24,28H,6-7,9-17H2,1-5H3,(H,29,30,31);1-3H3/t18-,20+,21+,22-,23+,24+,26+,27-;/m1./s1
• InChIKey: JMIBKZICJUFFKZ-KSGNISEOSA-N
• SMILES: C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)O)C)C.CN(C)C

Larsucosterol (trimethylamine)（Cat No.:I042841）is a chemical compound known for its potential therapeutic applications, particularly in the field of cancer and metabolic disease research. It is a derivative of larsucosterol, a natural steroidal compound, and features a trimethylamine functional group that enhances its biological activity. This modification is believed to increase its solubility and bioavailability. Larsucosterol (trimethylamine) has shown promise in modulating various cellular processes, including lipid metabolism and cell signaling. Its ability to interact with specific enzymes makes it a candidate for further exploration in drug development, particularly for metabolic and oncology-related disorders.